SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
Adams, Reyna, Turner, Ream are US concerns ahead of Copa America
Beijing urges Manila to act with caution
Ambassador encourages education exchanges between China and UK
Top political advisor highlights readiness to deepen relations with DPRK
Jon Wysocki dead at 53: Staind drummer passes away
Moscow tells Kyiv to extradite security chief
Truce remains elusive in Gaza as talks fall flat
Washington draws flak for sending wrong signal
Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
China Coast Guard responds to trespassing of illegal Philippine ships
I was 'brokefished' by my friend for £400
Xi congratulates Prabowo Subianto on election as Indonesian president